1-20 of 133,750 results for subject:NHS
Librarians' tools
- Search time
- 0.358 seconds
- Solr query time
- 0.115 seconds
- Search query
- subject:NHS
- We searched for
- subject_t:NHS OR subject_t:"National health service" OR subject_ses:92154
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
To ask His Majesty's Government on how many days since 1 October 2023 has there been a negative daily change in the count of people with an NHS national data opt-out; and why negative figures are not visible in the NHS National Data Opt-Out Dashboard.
To ask His Majesty's Government on how many days since 1 October 2023 has there been a negative daily change in the count of people with an NHS national data opt-out; and why negative figures are not visible in the NHS National Data Opt-Out Dashboard.
Negative daily change figures are visible on the National Data Opt-Out dashboard. Between 1 October 2023 and 14 July 2026, the latest dashboard update, there have been 278 days with a negative daily change in the count of people with a National Data Opt-Out according to the dashboard.
To ask the Secretary of State for the Home Department, what guidance is issued to police forces on the priority given to reports of violence and aggression against NHS staff, including in emergency departments.
To ask the Secretary of State for the Home Department, what guidance is issued to police forces on the priority given to reports of violence and aggression against NHS staff, including in emergency departments.
Police forces are operationally independent from Government and are responsible for decisions relating to their resourcing to respond to and investigate crime.
To ask the Secretary of State for Health and Social Care, what steps she is taking to a) reduce and b) support victims of scam texts from people pretending to be the NHS.
To ask the Secretary of State for Health and Social Care, what steps she is taking to a) reduce and b) support victims of scam texts from people pretending to be the NHS.
NHS England has worked with the National Cyber Security Centre and telecommunications partners to implement technical measures to reduce fraudulent text messages purporting to be from National Health Service organisations. NHS England has also issued guidance to organisations that promotes clear and consistent use of SMS to help patients recognise genuine NHS communications. Patients who receive a suspicious message are encouraged to follow the National Cyber Security Centre's guidance on spotting and reporting scam texts.
Additionally, any scam texts should be reported to Report Fraud, the national reporting service for fraud and cybercrime in the United Kingdom. They can be contacted by phone on 0300 123 2040, or on their website at the following link:
https://www.reportfraud.police.uk/reporting-a-fraud/
More generally, the Government works closely with industry, regulators, law enforcement, and consumer groups to close the vulnerabilities that criminals exploit and stop scams reaching people. On 5 November 2025, the Government launched the second Telecoms Fraud Charter to go further in identifying, preventing, and disrupting telecoms fraud. We are also working closely with Ofcom to stop more cases of number ‘spoofing’, where scammers impersonate UK numbers and trick people into thinking they’re speaking to banks, telephone companies, or other legitimate organisations. Further details are available at the link below:
https://www.gov.uk/government/publications/fraud-sector-charter-telecommunications
To ask His Majesty's Government how many of the 10 published NHS federated data platform case studies were drafted, contributed to, or reviewed prior to publication, by Palantir Technologies, its subsidiaries, or associated contractors, rather than authored solely by the featured NHS Trust or integrated care board.
To ask His Majesty's Government how many of the 10 published NHS federated data platform case studies were drafted, contributed to, or reviewed prior to publication, by Palantir Technologies, its subsidiaries, or associated contractors, rather than authored solely by the featured NHS Trust or integrated care board.
I refer the Noble Lord to the text on the NHS England website explaining how the case studies in question were drawn up, which, for ease of reference, is reproduced below:
“Our case studies showcase how NHS organisations are using the NHS Federated Data Platform to drive innovation and improve care. While NHS England supports their production, the views and content presented are those of the individual trusts or integrated care boards featured.
Each case study focuses on a specific challenge, the solution implemented, and the measurable impact for patients and staff. Whether it’s increasing theatre efficiency, reducing cancellations, or enabling faster diagnoses, these examples demonstrate the power of data to support better decision-making and service delivery.
Explore the case studies and see how the NHS Federated Data Platform could help solve challenges in your area.”
To ask His Majesty's Government how many of the 10 published NHS federated data platform case studies were drafted, contributed to, or reviewed prior to publication, by NHS England officials or external communications contractors acting on their behalf, rather than authored solely by the featured NHS Trust or integrated care...
To ask His Majesty's Government how many of the 10 published NHS federated data platform case studies were drafted, contributed to, or reviewed prior to publication, by NHS England officials or external communications contractors acting on their behalf, rather than authored solely by the featured NHS Trust or integrated care...
I refer the Noble Lord to the text on the NHS England website explaining how the case studies in question were drawn up, which, for ease of reference, is reproduced below:
“Our case studies showcase how NHS organisations are using the NHS Federated Data Platform to drive innovation and improve care. While NHS England supports their production, the views and content presented are those of the individual trusts or integrated care boards featured.
Each case study focuses on a specific challenge, the solution implemented, and the measurable impact for patients and staff. Whether it’s increasing theatre efficiency, reducing cancellations, or enabling faster diagnoses, these examples demonstrate the power of data to support better decision-making and service delivery.
Explore the case studies and see how the NHS Federated Data Platform could help solve challenges in your area.”
To ask His Majesty's Government who is responsible for approving the operating model changes which the Frontline Productivity Programme's senior responsible owner has said fall outside their powers; and by what date they expect those changes to be approved.
To ask His Majesty's Government who is responsible for approving the operating model changes which the Frontline Productivity Programme's senior responsible owner has said fall outside their powers; and by what date they expect those changes to be approved.
NHS England has accepted the findings of the recent Gateway Review and is taking forward the agreed actions as a priority. The review identified the need for a clearer, integrated articulation of how the Frontline Productivity Programme’s investments and delivery activities combine to achieve the productivity outcomes set out in the approved business case. The framework will be completed by the end of October 2026, and will establish a consistent end-to-end view of delivery, benefits, ownership, and reporting across the programme, supporting the management of dependencies, reducing the risk of duplication, and strengthening future investment decisions.
To ask His Majesty's Government what plans they have to establish an integrated benefits framework for the Frontline Productivity Programme, given the latest gateway review's finding that no such framework currently exists to demonstrate delivery of the productivity benefits set out in its approved business case.
To ask His Majesty's Government what plans they have to establish an integrated benefits framework for the Frontline Productivity Programme, given the latest gateway review's finding that no such framework currently exists to demonstrate delivery of the productivity benefits set out in its approved business case.
NHS England has accepted the findings of the recent Gateway Review and is taking forward the agreed actions as a priority. The review identified the need for a clearer, integrated articulation of how the Frontline Productivity Programme’s investments and delivery activities combine to achieve the productivity outcomes set out in the approved business case. The framework will be completed by the end of October 2026, and will establish a consistent end-to-end view of delivery, benefits, ownership, and reporting across the programme, supporting the management of dependencies, reducing the risk of duplication, and strengthening future investment decisions.
To ask His Majesty's Government what assessment they have made of the effect of the 50 per cent cut to integrated care board running costs and the wider restructuring of NHS England on regional capacity to deliver the Frontline Productivity Programme; and what additional support they intend to provide to regions...
To ask His Majesty's Government what assessment they have made of the effect of the 50 per cent cut to integrated care board running costs and the wider restructuring of NHS England on regional capacity to deliver the Frontline Productivity Programme; and what additional support they intend to provide to regions...
NHS England has accepted the findings of the recent Gateway Review and is taking forward the agreed actions as a priority. The review identified the need for a clearer, integrated articulation of how the Frontline Productivity Programme’s investments and delivery activities combine to achieve the productivity outcomes set out in the approved business case. The framework will be completed by the end of October 2026, and will establish a consistent end-to-end view of delivery, benefits, ownership, and reporting across the programme, supporting the management of dependencies, reducing the risk of duplication, and strengthening future investment decisions.
To ask the Secretary of State for Health and Social Care, what her planned time frame is for giving NHS primary care dentists access to the single patient record.
To ask the Secretary of State for Health and Social Care, what her planned time frame is for giving NHS primary care dentists access to the single patient record.
The Health Bill before Parliament will provide the legislative framework for the Single Patient Record. The programme is developing the technical and delivery approach, working with healthcare professionals, patients, the public, National Health Service providers, and suppliers. Initial work is focused on a Core Record and early priority areas, including maternity and frailty, as part of a phased approach to implementation.
The detailed scope and sequencing, including access for primary care dentistry, are still being developed, and no specific date has yet been set. The programme will engage dental professionals and relevant system suppliers as requirements and implementation plans are confirmed.
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what assessment has been made of whether existing legislation provides sufficient powers...
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what assessment has been made of whether existing legislation provides sufficient powers...
Anti-competitive behaviour, including excessive pricing and abuse of a dominant position, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.
As the press release cited by the Hon. Member demonstrates, the current legal and enforcement regime in this area allows for effective action to be taken in relevant cases, and the responsible agencies will continue to take such action whenever necessary.
Following the recent Court of Appeal judgment upholding the CMA's findings in relation to hydrocortisone tablets, the Department is considering the appropriate next steps. Any sums recovered are returned to the NHS and support frontline patient care.
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what recent discussions havetaken place with the Competition and Markets Authority on...
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what recent discussions havetaken place with the Competition and Markets Authority on...
Anti-competitive behaviour, including excessive pricing and abuse of a dominant position, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.
As the press release cited by the Hon. Member demonstrates, the current legal and enforcement regime in this area allows for effective action to be taken in relevant cases, and the responsible agencies will continue to take such action whenever necessary.
Following the recent Court of Appeal judgment upholding the CMA's findings in relation to hydrocortisone tablets, the Department is considering the appropriate next steps. Any sums recovered are returned to the NHS and support frontline patient care.
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what steps the Government is taking to recover costs incurred by the...
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what steps the Government is taking to recover costs incurred by the...
Anti-competitive behaviour, including excessive pricing and abuse of a dominant position, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.
As the press release cited by the Hon. Member demonstrates, the current legal and enforcement regime in this area allows for effective action to be taken in relevant cases, and the responsible agencies will continue to take such action whenever necessary.
Following the recent Court of Appeal judgment upholding the CMA's findings in relation to hydrocortisone tablets, the Department is considering the appropriate next steps. Any sums recovered are returned to the NHS and support frontline patient care.
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, whether the Government plans to introduce additional safeguards to prevent a recurrence...
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, whether the Government plans to introduce additional safeguards to prevent a recurrence...
Anti-competitive behaviour, including excessive pricing and abuse of a dominant position, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.
As the press release cited by the Hon. Member demonstrates, the current legal and enforcement regime in this area allows for effective action to be taken in relevant cases, and the responsible agencies will continue to take such action whenever necessary.
Following the recent Court of Appeal judgment upholding the CMA's findings in relation to hydrocortisone tablets, the Department is considering the appropriate next steps. Any sums recovered are returned to the NHS and support frontline patient care.
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what recent discussions have taken place with NHS England on measures to...
To ask the Secretary of State for Health and Social Care, with reference to the press release entitled Court upholds CMA findings that firms charged excessive and unfair prices for lifesaving NHS-funded medicine, published on 29 July 2026, what recent discussions have taken place with NHS England on measures to...
Anti-competitive behaviour, including excessive pricing and abuse of a dominant position, is a matter for the Competition and Markets Authority (CMA). The Department asks the CMA to investigate where it has concerns about abuses of competition law for generic medicines and where companies are found by the CMA to be in breach of the legislation, the Department will seek damages and invest that money back into the National Health Service.
As the press release cited by the Hon. Member demonstrates, the current legal and enforcement regime in this area allows for effective action to be taken in relevant cases, and the responsible agencies will continue to take such action whenever necessary.
Following the recent Court of Appeal judgment upholding the CMA's findings in relation to hydrocortisone tablets, the Department is considering the appropriate next steps. Any sums recovered are returned to the NHS and support frontline patient care.
To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of patients experiencing difficulties accessing prescription services through the NHS App.
To ask the Secretary of State for Health and Social Care, what estimate she has made of the number of patients experiencing difficulties accessing prescription services through the NHS App.
The Hon. Member can find advice on how to use the NHS App to order prescriptions at the following link:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the a) accessibility and b) usability of the NHS App prescription service.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the a) accessibility and b) usability of the NHS App prescription service.
The Hon. Member can find advice on how to use the NHS App to order prescriptions at the following link:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of IT systems used by primary care providers with the NHS App and systems used in secondary care; and what steps his Department is taking to improve interoperability between these systems.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the compatibility of IT systems used by primary care providers with the NHS App and systems used in secondary care; and what steps his Department is taking to improve interoperability between these systems.
The NHS App is able to integrate with all general practice core clinical systems, most online consultation solutions, and the majority of patient messaging platforms. It is also integrated with all but two acute trusts, all specialist trusts, and several mental health and community trust solutions for appointment management. As part of delivering the 10-Year Health Plan, NHS England is reviewing the standards and capabilities required across primary and secondary care digital solutions to support more joined-up care through the NHS App as a single point of access.
NHS England has launched a Digital Pathways Registry, which will raise the baseline standards expected of digital solutions in primary care. This includes strengthened requirements for interoperability, common data standards, and integration with national services such as the NHS App, supporting a more consistent and connected digital experience for patients and professionals.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of difficulty using the NHS App on accessing NHS prescriptions.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of difficulty using the NHS App on accessing NHS prescriptions.
The Hon. Member can find advice on how to use the NHS App to order prescriptions at the following link:
To ask the Secretary of State for Health and Social Care, whether NHS England provides guidance to GP practices on enabling patients to request regular medicines through the NHS App where those medicines are not configured as repeat prescriptions.
To ask the Secretary of State for Health and Social Care, whether NHS England provides guidance to GP practices on enabling patients to request regular medicines through the NHS App where those medicines are not configured as repeat prescriptions.
The Hon. Member can find advice on how to use the NHS App to order prescriptions at the following link:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the ability of patients to request repeat prescriptions through the NHS App for medicines that were previously prescribed as acute medications.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the ability of patients to request repeat prescriptions through the NHS App for medicines that were previously prescribed as acute medications.
The Hon. Member can find advice on how to use the NHS App to order prescriptions at the following link: